The increase of the CSF sTREM2 in AD patients often precedes the decline in cognition, and the level of sTREM2 is positively correlated with the level of hyperphosphorylated tau protein in the cerebrospinal fluid (13, 14). The gene discussed is MAPT; the disease is Alzheimer disease.